Monday, October 30, 2017 - The Journal of the American Medical Association (JAMA) published findings of a study this week that may inform the outcomes of Monsanto Roundup cancer lawsuits. The study, which was conducted over a 25-year period in Southern California, measures glyphosate levels over time in the study participants. Glyphosate is the active ingredient in Roundup.
Very few studies to date have examined glyphosate levels in humans, or the effect of the substance on human health. This most recent study, entitled ‘Excretion of the Herbicide Glyphosate in Older Adults Between 1993 and 2016‘, aims to build the body of scientific research on the subject, helping researchers and food safety regulators to better understand the impacts of widespread herbicide use on produce and in our communities.
From 1993 to 2016, urine samples were collected regularly from adults over the age of 50 adn tested for glyphosate. During that time span, glyphosate levels in the study participants‘ urine rose 500%. Use of Roundup increased by 1208% between 1993 and 2016. Roundup, which was designed for use with genetically modified crops, is applied to food crops but only kills the unwanted weeds. Many weeds have developed resistance to Roundup, resulting in more of the substance being applied to farm fields. Humans can come into contact with glyphosate directly, when they apply Roundup while gardening or landscaping, or environmentally, when the herbicide is sprayed on fields in a farming community.
The study, which was conducted by Paul Mills, PhD, a professor of public health at UC-San Diego, establishes the rising rates of glyphosate in humans but does not extrapolate on what impact this may have. According to the researchers, chronic exposure to glyphosate in Roundup can cause adverse effects and health problems. In July of 2017, glyphosate and Roundup were classified as ‘probable‘ carcinogens in California. The risk of Roundup cancer is under further investigation.
Dr. Mills plans to next conduct ongoing research on liver disease in persons with elevated glyphosate levels, in order to determine whether there is a correlation between Roundup and liver disease. This particular direction of study is related to a U.K. study of the effect of glyphosate on rats, which detected higher rate of nonalcoholic fatty liver disease in rats with 1/100 of the quantity of glyphosate in their urine as the human test subjects.
Persons and families of persons who have developed cancer after exposure to Roundup may be entitled to compensation by filing Monsanto Roundup cancer lawsuits. Our Monsanto Roundup attorneys are now offering free, no-obligation Roundup cancer case reviews to persons who match this description. Use this site‘s contact form to access your free case review today; an experienced Monsanto Roundup lawyer will be in contact with you promptly.
The Onder Law Firm is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O‘Leary & Peterson has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm‘s attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.